These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37580729)

  • 1. Association of red cell distribution width with pulmonary arterial hypertension in patients with mixed connective tissue disease.
    Jin Y; Guo G; Wang C; Jiang B
    BMC Pulm Med; 2023 Aug; 23(1):299. PubMed ID: 37580729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicentre study.
    Chaigne B; Chevalier K; Boucly A; Agard C; Baudet A; Bourdin A; Chabanne C; Cottin V; Fesler P; Goupil F; Jego P; Launay D; Lévesque H; Maurac A; Mohamed S; Tromeur C; Rottat L; Sitbon O; Humbert M; Mouthon L
    Rheumatology (Oxford); 2023 Oct; 62(10):3261-3267. PubMed ID: 36727465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nailfold capillaroscopy abnormalities and pulmonary hypertension in mixed connective tissue disease and systemic sclerosis patients.
    Munteanu A; Kundnani NR; Caraba A
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(4):1314-1326. PubMed ID: 38436165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractional exhaled nitric oxide in idiopathic pulmonary arterial hypertension and mixed connective tissue disease complicating pulmonary hypertension.
    Xu J; Sun X; Cao Y; Zhu H; Yang W; Liu J; Guo J
    BMC Pulm Med; 2024 Apr; 24(1):199. PubMed ID: 38654208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of pulmonary arterial hypertension in patients with mixed connective tissue disease: a systematic review and meta-analysis.
    Hassan AB; Hozayen RF; Mustafa ZS; Lundberg IE; Jahrami HA
    Clin Exp Rheumatol; 2023 Nov; 41(11):2301-2311. PubMed ID: 37497727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension.
    Vegh J; Szodoray P; Kappelmayer J; Csipo I; Udvardy M; Lakos G; Aleksza M; Soltesz P; Szilágyi A; Zeher M; Szegedi G; Bodolay E
    Scand J Immunol; 2006 Jul; 64(1):69-76. PubMed ID: 16784493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis.
    Distler O; Ofner C; Huscher D; Jordan S; Ulrich S; Stähler G; Grünig E; Held M; Ghofrani HA; Claussen M; Lange TJ; Klose H; Rosenkranz S; Vonk-Noordegraaf A; Vizza CD; Delcroix M; Opitz C; Pausch C; Scelsi L; Neurohr C; Olsson KM; Coghlan JG; Halank M; Skowasch D; Behr J; Milger K; Remppis BA; Skride A; Jureviciene E; Gumbiene L; Miliauskas S; Löffler-Ragg J; Wilkens H; Pittrow D; Hoeper MM; Ewert R
    Rheumatology (Oxford); 2024 Apr; 63(4):1139-1146. PubMed ID: 37462520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diastolic function of the heart in mixed connective tissue disease.
    Végh J; Hegedus I; Szegedi G; Zeher M; Bodolay E
    Clin Rheumatol; 2007 Feb; 26(2):176-81. PubMed ID: 16865311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Connective Tissue Growth Factor as a Biomarker of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Adults.
    Liu W; Hua Y; Zheng D; Lv W; Zhang W; Chen Q; Huang R; Li X
    Circ J; 2023 Mar; 87(4):527-535. PubMed ID: 36843115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid progression to pulmonary arterial hypertension crisis associated with mixed connective tissue disease in an 11-year-old girl.
    Okura Y; Takezaki S; Yamazaki Y; Yamada M; Kobayashi I; Ariga T
    Eur J Pediatr; 2013 Sep; 172(9):1263-5. PubMed ID: 23686514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-survival motor neuron complex antibodies as a novel biomarker for pulmonary arterial hypertension and interstitial lung disease in mixed connective tissue disease.
    Todoroki Y; Satoh M; Kubo S; Kosaka S; Fukuyo S; Nakatsuka K; Saito K; Tanaka S; Nakayamada S; Tanaka Y
    Rheumatology (Oxford); 2024 Apr; 63(4):1068-1075. PubMed ID: 37421400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
    Cansu DÜ; Korkmaz C
    Clin Rheumatol; 2023 Oct; 42(10):2601-2610. PubMed ID: 36396789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD.
    Todoroki Y; Kubo S; Nakano K; Miyazaki Y; Ueno M; Satoh-Kanda Y; Kanda R; Miyagawa I; Hanami K; Nakatsuka K; Saito K; Nakayamada S; Tanaka Y
    Rheumatology (Oxford); 2022 Nov; 61(12):4875-4884. PubMed ID: 35285493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two patients with mixed connective tissue disease complicated by pulmonary arterial hypertension showing contrasting responses to pulmonary vasodilators.
    Kusaka K; Nakano K; Iwata S; Kubo S; Nishida T; Tanaka Y
    Mod Rheumatol Case Rep; 2020 Jul; 4(2):253-261. PubMed ID: 33087021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of Red Cell Width Distribution (RDW) in the Assessment of Children with Pulmonary Arterial Hypertension (PAH).
    Zuk M; Migdal A; Dominczak J; Brzezinska-Rajszys G
    Pediatr Cardiol; 2019 Apr; 40(4):820-826. PubMed ID: 30830279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red Cell Distribution Width and Platelet Count as Biomarkers of Pulmonary Arterial Hypertension in Patients with Connective Tissue Disorders.
    Bellan M; Giubertoni A; Piccinino C; Dimagli A; Grimoldi F; Sguazzotti M; Burlone ME; Smirne C; Sola D; Marino P; Pirisi M; Sainaghi PP
    Dis Markers; 2019; 2019():4981982. PubMed ID: 31275447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of pulmonary arterial pressure in patients with connective tissue disease-associated pulmonary arterial hypertension by myocardial perfusion imaging.
    Wang Z; Li J; Wang X; Liu M; Liao M; Zhang C; Shang X
    Ann Noninvasive Electrocardiol; 2022 Mar; 27(2):e12927. PubMed ID: 34908208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).
    Wigley FM; Lima JA; Mayes M; McLain D; Chapin JL; Ward-Able C
    Arthritis Rheum; 2005 Jul; 52(7):2125-32. PubMed ID: 15986394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell distribution width as a related factor of pulmonary arterial hypertension in patients with systemic sclerosis.
    Zhao J; Mo H; Guo X; Wang Q; Xu D; Hou Y; Tian Z; Liu Y; Wang H; Lai J; Li M; Zeng X
    Clin Rheumatol; 2018 Apr; 37(4):979-985. PubMed ID: 29164429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.